ReviewFrontiers in immunology2023

Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus.

Yi-Giien Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.